logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

David S. Boyer

retina-vitreous associates medical group
H指数:64
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gildeuretinol Acetate vs Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The SAGA Randomized Clinical Trial

吉尔杜雷汀醇醋酸盐与安慰剂治疗年龄相关性黄斑变性继发性地理性萎缩的比较：SAGA随机临床试验

Ophthalmology Retina
IF5.7
2026-06-030
OAAI
David S. Boyer; Leonide Saad; Ilyas Washington; Alexander Melamud; Kenneth B. Graham; Adrian E. O’Malley; Gabrielle M. DeBartolomeo; Honghua Jiang; Lindsey D. Harris; Christine N. Kay; Philip J. Ferrone; Seemi Khan
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: 96-Week Results from the Randomized Phase 2/3 PHOTON Trial

玻璃体内注射Aflibercept 8 mg治疗糖尿病黄斑水肿：随机II/III期PHOTON试验96周结果

Ophthalmology
IF9.5
2025-11-100
OAAI
Diana V. Do; Charles C. Wykoff; Sobha Sivaprasad; David M. Brown; David S. Boyer; Taiji Sakamoto; Peter Win; Sunir Joshi; Hani Salehi-Had; András Seres; Alyson J. Berliner; Sergio Leal; Robert Vitti; Karen W. Chu; Kimberly Reed; Yenchieh Cheng; Rafia Bhore; Zhanying Bai; Ursula Schmidt-Ott; Thomas Schmelter; Andrea Schulze; Zoran Hasanbasic; Peter J. Morgan-Warren; Xin Zhang; Boaz Hirshberg; George D. Yancopoulos
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial

MCO-010光遗传疗法的安全性与有效性：在美国星状黄斑变性患者中的研究（STARLIGHT）：一项开放标签、多中心、Ⅱ期临床试验

eClinicalMedicine
IF10
2025-08-140
PREAI
Byron L. Lam; Vitaliy Zak; Victor H. Gonzalez; Ninel Z. Gregori; Sai H. Chavala; Subrata Batabyal; Michael Carlson; Sanghoon Kim; Ananta Ayyagari; Jean Chang; Hayley Lane; Nozhat Choudry; John Koester; Mark Von Tress; Jody Piltz-Seymour; Najam A. Sharif; Stephen H. Tsang; Vinit B. Mahajan; David S. Boyer; Allen C. Ho; Samuel B. Barone; Samarendra K. Mohanty
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies

Pegcetacoplan治疗与年龄相关性黄斑变性相关的地图样萎缩：OAKS和DERBY临床研究的简明语言摘要

immunotherapy
IF2.3
2025-01-170
OA
Jeffrey S Heier; Eleonora M Lad; Frank G Holz; Philip J Rosenfeld; Robyn H Guymer; David Boyer; Federico Grossi; Caroline R Baumal; Jean-Francois Korobelnik; Jason S Slakter; Nadia K Waheed; Ravi Metlapally; Ian Pearce; Nathan Steinle; Anibal A Francone; Allen Hu; David R Lally; Pascal Deschatelets; Cedric Francois; Caleb Bliss; Giovanni Staurenghi; Jordi Monés; Rishi P Singh; Ramiro Ribeiro; Charles C Wykoff
Longitudinal Changes in Learnings from PANORAMA

PANORAMA学习成果的纵向变化

OPHTHALMOLOGY RETINA
IF5.7
2025-01-010
OAAI
Wykoff, Charles c.; Do, Diana V.; Clark, W. loyd; Boyer, David s.; Dhoot, Dilsher s.; Marcus, Dennis m.; Vitti, Robert; Berliner, Alyson j.; Reed, Kimberly; Cheng, Yenchieh; Moini, Hadi; Brown, David m.
Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular Edema

Phase 1b剂量递增研究：评估Sozinibercept抑制血管内皮生长因子C和D与Aflibercept联合治疗糖尿病黄斑水肿的疗效

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY
IF2.6
2024-12-190
OA
Boyer, David S.; Steinle, Nathan C.; Pearlman, Joel A.; Stone, Cameron M.; Crawford, Courtney; Gupta, Sunil; Dugel, Pravin U.; Baldwin, Megan E.; Leitch, Ian M.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
LANCET
IF88.5
2024-03-019
PRE
Brown, David M.; Boyer, David S.; Do, Diana, V; Wykoff, Charles C.; Sakamoto, Taiji; Win, Peter; Joshi, Sunir; Salehi-Had, Hani; Seres, Andras; Berliner, Alyson J.; Leal, Sergio; Vitti, Robert; Chu, Karen W.; Reed, Kimberly; Rao, Rohini; Cheng, Yenchieh; Sun, Wei; Voronca, Delia; Bhore, Rafia; Schmidt-Ott, Ursula; Schmelter, Thomas; Schulze, Andrea; Zhang, Xin; Hirshberg, Boaz; Yancopoulos, George; Sivaprasad, Sobha
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

ixoberogene soroparvovec在美国新生血管性年龄相关性黄斑变性中的安全性和有效性 (OPTIC): 一项为期两年的多中心前瞻性1期研究

ECLINICALMEDICINE
IF10
2024-01-0117
OAAI
Khanani, Arshad M.; Boyer, David S.; Wykoff, Charles C.; Regillo, Carl D.; Busbee, Brandon G.; Pieramici, Dante; Danzig, CarlJ.; Joondeph, Brian C.; Major Jr, James C.; Turpcu, Adam; Kiss, Szilard
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Pegcetacotlan治疗继发于年龄相关性黄斑变性的地图状萎缩 (OAKS和DERBY): 两项多中心，随机，双盲，假对照，3期试验

LANCET
IF88.5
2023-10-01114
PRE
Heier, Jeffrey S.; Lad, Eleonora M.; Holz, Frank G.; Rosenfeld, Philip J.; Guymer, Robyn H.; Boyer, David; Grossi, Federico; Baumal, Caroline R.; Korobelnik, Jean-Francois; Slakter, Jason S.; Waheed, Nadia K.; Metlapally, Ravi; Pearce, Ian; Steinle, Nathan; Francone, Anibal A.; Hu, Allen; Lally, David R.; Deschatelets, Pascal; Francois, Cedric; Bliss, Caleb; Staurenghi, Giovanni; Mones, Jordi; Singh, Rishi P.; Ribeiro, Ramiro; Wykoff, Charles C.

研究方向

暂未获取到该数据
D
David M. Brown
H 指数:74论文数:443被引数:2.4万
J
Jeffrey S. Heier
H 指数:73论文数:296被引数:3.4万
C
Charles C. Wykoff
H 指数:66论文数:506被引数:2.2万
A
Alyson J. Berliner
H 指数:29论文数:104被引数:9,303
R
Robert Vitti
H 指数:35论文数:143被引数:1.0万
Q
Quan Dong Nguyen
H 指数:67论文数:761被引数:2.4万
W
W. Lloyd Clark
H 指数:26论文数:76被引数:3,657
P
Peter A. Campochiaro
H 指数:112论文数:543被引数:4.2万
D
Dennis M. Marcus
H 指数:44论文数:196被引数:1.1万
B
Baruch D. Kuppermann
H 指数:52论文数:457被引数:1.1万